Paper28292983
Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application.
Kerantzas CA and 1 other. mBio, 2017. Cited by 129 papers, by iCite.
Cite this record
ConductScience Library. Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application. Papers, record 28292983. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28292983
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitubercular Agents | Major topic |
| Drug Therapy, Combination | Major topic |
| Tuberculosis | Major topic |
| Aminosalicylic Acid | |
| Drug Discovery | |
| History, 20th Century | |
| History, 21st Century | |
| Humans | |
| Streptomycin | |
| United Kingdom |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI026170 | NIAID NIH HHS | United States | R01AI026170 | PubMed and NIH | NIH RePORTER |
| R01 AI097548 | NIAID NIH HHS | United States | R01AI097548 | PubMed and NIH | NIH RePORTER |
| R37 AI026170 | NIAID NIH HHS | United States | R01AI026170 | PubMed and NIH | NIH RePORTER |
| T32 GM007288 | NIGMS NIH HHS | United States | T32GM007288 | PubMed and NIH | NIH RePORTER |
| R37AI026170 | NIH | NIH RePORTER |
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14164615 | PRODUCTION OF PENICILLIN IN THE UNITED STATES (1941-1946). | Nature | 1964 | https://conductscience.org/library/papers/14164615 | PubMed |
| 2 | 16436705 | Discovery of FabH/FabF inhibitors from natural products. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16436705 | PubMed |
| 3 | 17278059 | Mutant selection window hypothesis updated. | Clin Infect Dis | 2007 | https://conductscience.org/library/papers/17278059 | PubMed |
| 5 | 18626052 | The first use of penicillin in the United States. | Ann Intern Med | 2008 | https://conductscience.org/library/papers/18626052 | PubMed |
| 6 | 23179675 | Molecular biology of drug resistance in Mycobacterium tuberculosis. | Curr Top Microbiol Immunol | 2013 | https://conductscience.org/library/papers/23179675 | PubMed |
| 9 | 22564842 | Induction of mycobacterial resistance to quinolone class antimicrobials. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22564842 | PubMed |
| 11 | 10529902 | Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. | Int J Tuberc Lung Dis | 1999 | https://conductscience.org/library/papers/10529902 | PubMed |
| 12 | 26985890 | Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/26985890 | PubMed |
| 13 | 23768488 | Microbial persistence and the road to drug resistance. | Cell Host Microbe | 2013 | https://conductscience.org/library/papers/23768488 | PubMed |
| 14 | 49163 | Short-course chemotherapy for pulmonary tuberculosis. | Am Rev Respir Dis | 1975 | https://conductscience.org/library/papers/49163 | PubMed |
| 15 | 19679737 | The introduction of 'chemotherapy' using arsphenamine - the first magic bullet. | J R Soc Med | 2009 | https://conductscience.org/library/papers/19679737 | PubMed |
| 16 | 26999656 | Persistence and resistance as complementary bacterial adaptations to antibiotics. | J Evol Biol | 2016 | https://conductscience.org/library/papers/26999656 | PubMed |
| 18 | 413477 | A taxonomic study of the Penicillium chrysogenum series. | Antonie Van Leeuwenhoek | 1977 | https://conductscience.org/library/papers/413477 | PubMed |
| 20 | 7030377 | Whither short-course chemotherapy? | Br J Dis Chest | 1981 | https://conductscience.org/library/papers/7030377 | PubMed |
| 21 | 11702082 | How many antibiotics are produced by the genus Streptomyces? | Arch Microbiol | 2001 | https://conductscience.org/library/papers/11702082 | PubMed |
| 23 | 23629505 | Platforms for antibiotic discovery. | Nat Rev Drug Discov | 2013 | https://conductscience.org/library/papers/23629505 | PubMed |
| 27 | 13776497 | A new synthetic compound with antituberculous activity in mice: ethambutol (dextro-2,2'-(ethylenediimino)-di-l-butanol). | Am Rev Respir Dis | 1961 | https://conductscience.org/library/papers/13776497 | PubMed |
| 28 | 1541313 | Further observations on penicillin. 1941. | Eur J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1541313 | PubMed |
| 38 | 8863420 | Proposal for two new genera, Brevibacillus gen. nov. and Aneurinibacillus gen. nov. | Int J Syst Bacteriol | 1996 | https://conductscience.org/library/papers/8863420 | PubMed |
| 40 | 3543562 | The history of the therapeutic use of crude penicillin. | Med Hist | 1987 | https://conductscience.org/library/papers/3543562 | PubMed |
Cited by102
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948277 | Synergistic antimycobacterial activity of Piper longum and Cressa cretica extracts and their effects on the expression of rpoB, gyrA and gyrB genes in Mycobacterium tuberculosis. | Med Int (Lond) | 2026 | https://conductscience.org/library/papers/42948277 | PubMed |
| 42839156 | A Comparison of Mechanisms Driving Lesion Outcomes During Lung Tumor and Tuberculosis Granuloma Formation. | Bull Math Biol | 2026 | https://conductscience.org/library/papers/42839156 | PubMed |
| 42793156 | Membrane Disruption and Charge Neutralization Drive Synergy Between LL37-Derived Peptides and Polymyxins Against E. coli. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793156 | PubMed |
| 42494476 | The Evolution of Knockdown Resistance: Genotypic and Phenotypic Insights Into Aedes aegypti Insecticide Resistance. | Evol Appl | 2026 | https://conductscience.org/library/papers/42494476 | PubMed |
| 42439564 | Dual inhibition of respiratory complexes in Mycobacterium tuberculosis results in bacterial killing. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42439564 | PubMed |
| 42196226 | Two Worlds, One Battle: How Bacteria and Malignancies Converge on Drug Resistance. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196226 | PubMed |
| 42182461 | In vitro dormancy models improve ability to predict treatment response in severe marmoset tuberculosis lesions. | bioRxiv | 2026 | https://conductscience.org/library/papers/42182461 | PubMed |
| 41736535 | Antibiotic hybrids: A promising strategy to replenish the pipeline and combat antimicrobial resistance. | J Microbiol | 2026 | https://conductscience.org/library/papers/41736535 | PubMed |
| 41718947 | Antimicrobial Armageddon: The Professional Guide to Conquering Antibiotic Resistance. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/41718947 | PubMed |
| 41693264 | Preclinical Pharmacokinetics and Pharmacodynamics of Antibiotic Adjuvants. | ACS Infect Dis | 2026 | https://conductscience.org/library/papers/41693264 | PubMed |
| 41599169 | Advancing Tuberculosis Treatment with Next-Generation Drugs and Smart Delivery Systems. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41599169 | PubMed |
| 41529103 | Defining the Mechanism of Action and Resistance of New Mycobacterium abscessus MmpL3 Inhibitors. | ACS Chem Biol | 2026 | https://conductscience.org/library/papers/41529103 | PubMed |
| 41281587 | A novel machine-learning based optimization: identifying new treatment regimens for tuberculosis. | Numer Algebr Control Optim | 2025 | https://conductscience.org/library/papers/41281587 | PubMed |
| 41186421 | Drug-resistant tuberculosis: a priority pathogen for enhanced public health research and practice. | Clin Microbiol Rev | 2025 | https://conductscience.org/library/papers/41186421 | PubMed |
| 41181601 | GEODE: an in silico tool that translates in vitro to in vivo predictions of tuberculosis antibiotic combination efficacy. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41181601 | PubMed |
| 41083887 | Bacterial cell envelope-targeting antibiotics. | Nat Rev Microbiol | 2026 | https://conductscience.org/library/papers/41083887 | PubMed |
| 40965512 | Deconvoluting drug interactions using M. tuberculosis physiologic processes: transcriptional disaggregation of the BPaL regimen in vivo. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/40965512 | PubMed |
| 40951570 | Advanced Therapeutic Interventions Targeting Mycobacterium Tuberculosis. | Arch Razi Inst | 2025 | https://conductscience.org/library/papers/40951570 | PubMed |
| 40934261 | Positive allosteric modulation of emodepside sensitive Brugia malayi SLO-1F and Onchocerca volvulus SLO-1A potassium channels by GoSlo-SR-5-69. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/40934261 | PubMed |
| 40559793 | Molecular Identification and Antimicrobial Resistance Characteristics of Extended-Spectrum Beta-Lactamase Producing Klebsiella pneumoniae Isolated from Captive Wild and Migratory Birds. | Vet Sci | 2025 | https://conductscience.org/library/papers/40559793 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28292983
GET https://conductscience.org/api/papers/v1/28292983/references?page=2